Status:
COMPLETED
Clinical Pharmacology of FYU-981 (Final Formulation)
Lead Sponsor:
Mochida Pharmaceutical Company, Ltd.
Collaborating Sponsors:
Fuji Yakuhin Co., Ltd.
Conditions:
Healthy
Eligibility:
MALE
20-35 years
Phase:
PHASE1
Brief Summary
This is a randomized, open-label, 2-period crossover study. The purpose of this study is to assess the pharmacokinetics and safety after single oral administration of final formulation of FYU-981 to h...
Eligibility Criteria
Inclusion
- Japanese healthy adult subjects
- Body mass index: \>=18.5 and \<25.0
Exclusion
- Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study
Key Trial Info
Start Date :
November 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 29 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03350373
Start Date
November 6 2017
End Date
November 29 2017
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
P-One Clinic
Hachiōji, Tokyo, Japan, 192-0071